Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × Methotrexate × 30 days × Clear all

NCT05663866 2026-04-13

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

Phase 2 Active not recruiting

68 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung